✦ LIBER ✦

LONG-TERM THIENOPYRIDINE THERAPY AND OUTCOMES IN PATIENTS WITH ACS TREATED WITH CORONARY STENTING: THE PRIMARY RESULTS OF THE TIMI-38 CORONARY STENT REGISTRY

✍ Scribed by Marc P. Bonaca; Eugene Braunwald; Sabina A. Murphy; Debra Miller; JP R. Herrman; Shmuel Gottlieb; Alberto Menozzi; Carolyn H. McCabe; Elliot M. Antman; Stephen W. Wiviott

Book ID: 118581713
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 272 KB
Volume: 57
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(11)60906-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stenting the stent: initial results and

Stenting the stent: initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis

✍ Fernando Alfonso; Angel Cequier; Javier Zueco; César Morı́s; Concepción P Suárez 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Long-Term Outcome in Patients Treated Wi

Long-Term Outcome in Patients Treated With Sirolimus-Eluting Stents in Complex Coronary Artery Lesions: 3-Year Results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) Trial

✍ Henning Kelbæk; Lene Kløvgaard; Steffen Helqvist; Jens F. Lassen; Lars R. Krusel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 260 KB

Influence of stent treatment strategies

Influence of stent treatment strategies in the long-term outcome of patients with long diffuse coronary lesions

✍ Manuel Pan; José Suárez de Lezo; Alfonso Medina; Miguel Romero; Sandra González; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views

Diffuse coronary lesions (length > 20 mm) are still considered high risk for percutaneous intervention even in the current stent era. We compared the 2-year outcome of patients with long diffuse stenosis treated by three different stent strategies. In addition, we also analyzed the possible factors

Duration of dual antiplatelet therapy an

Duration of dual antiplatelet therapy and outcomes after coronary stenting with the genous™ bio-engineered R stent™ in patients from the e-healing registry

✍ Peter Damman; Margo Klomp; Sigmund Silber; Marcel A. Beijk; Expedito E. Ribeiro; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 1 views

Intensive oral antiplatelet therapy for

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial

✍ Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Ivan Horvath; Matyas Kelt 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 247 KB

AS-221: In-Stent Restenosis in Patients

AS-221: In-Stent Restenosis in Patients with Coronary Artery Disease: Primary Survival Outcome, Short- and Long-Term Follow-Up Results, and Future Prospects in the Stent Era in Bangladesh

✍ Shams Munwar; A.H.M. Waliul Islam; Shahabuddin Talukder; A.Q.M. Reza 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB